Medifast Inc

Brassica Protection Products LLC is a Baltimore-based innovator specializing in nutritional ingredients derived from cruciferous vegetables, particularly broccoli. The company markets its TrueBroc brand of glucoraphanin, which is extracted from concentrated broccoli seeds, for use in dietary supplements, foods, and beverages. With a history of collaboration with researchers at Johns Hopkins School of Medicine since 1997, Brassica is committed to advancing the understanding of glucoraphanin and its active form, sulforaphane. The company also offers gourmet teas and coffees that feature its flagship ingredient, cementing its role in harnessing the health benefits of broccoli. Generated from the website

The Life Center is a wellness facility in Bel Air, MD, offering a variety of services aimed at promoting physical and mental well-being. With a focus on holistic approaches to health, The Life Center provides personalized care and support for individuals seeking to improve their overall quality of life. Generated from their business information

Yiseng US Biopharma is a global biopharmaceutical company specializing in the discovery, development, manufacturing, and commercialization of vaccines and therapeutic biologics for infectious diseases and cancer. With a dedicated team of over 800 employees and a presence in multiple countries, including China, Singapore, the United States, the United Arab Emirates, and the Philippines, Yiseng US Biopharma utilizes its proprietary PIKA immunomodulating technology platform to develop a diverse range of biotherapeutics targeting diseases such as COVID-19, hepatitis B, rabies, flu, and various forms of cancer. Through their PIKA technology, which activates multiple pathways of immune signaling, including TLR3, RIG-I, and MDA5, Yiseng US Biopharma is at the forefront of developing innovative antiviral vaccines, antiviral therapeutics, and anticancer therapeutics. Their pipeline includes PIKA-based vaccines for infectious diseases and PIKA-based immuno-oncology candidates that have demonstrated potent antitumor effects in preclinical studies. With a strong focus on advancing novel immunotherapeutics, Yiseng US Biopharma is committed to making significant contributions to the field of biopharmaceuticals.Generated from the website